secwatch.observer — SEC 8-K summary
======================================

Issuer:     LABCORP HOLDINGS INC. (LH)
CIK:        0000920148
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0000920148-26-000019
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Labcorp appoints John H. Sampson, M.D., Ph.D., to board of directors
--------------------------------------------------------------------

- Appointed John H. Sampson, M.D., Ph.D., to Board of Directors, effective February 9, 2026.
- Dr. Sampson is vice chancellor for health affairs and dean at CU Anschutz School of Medicine.
- He brings expertise in oncology, neuroscience, women's health, and personalized medicine.
- Previously senior vice president at Duke Health Integrated Practice.
- Will serve on the Quality and Compliance Committee of the Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/920148/000092014826000019/0000920148-26-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/920148/000092014826000019/lh-20260206.htm
  HTML page:      https://secwatch.observer/filing/0000920148-26-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer